Articles On Althea Group Holdings (ASX:AGH)

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

It was another positive close for the Australian bourse today with energy the standout sector. The ASX 200 closed 0.17% higher at 7,503 points while the ASX Emerging Companies Index gained 1.1% to close at 2,262 points. Leading the charge w...

Highlights Actinogen Medical has completed the global grant process for Xanamem with the official notification for the grant of its patent application in Brazil. Althea’s Canadian subsidiary, Peak Processing Solutions, has entered into...

In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 1.5% to 7,228.6 points. Four ASX shares that are not letting that hold them ba...

The Althea Group Holdings Ltd (ASX: AGH) share price is on course to end the week on a positive note. In morning trade, the cannabis company’s shares are up 4% to 36.5 cents. Why is the Althea share price climbing? Investors have been bidd...

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

The Bod Australia Ltd (ASX: BDA) share price is a strong performer today following the release of a sales update. At the time of writing, shares in the CBD and hemp healthcare products company are up 3% to 35 cents. What’s driving the Bod...

Connecticut has become the latest US state to legalise recreational use of marijuana. The state’s governor has just signed a bill to allow people aged 21 and older to possess and consume marijuana, making it the 19th US state to do so. Here...

Summary Afterpay jumps on plans to expand reach with U.S. merchants Althea enters South African cannabis market worth US$667 million Bluechiip shares close strong on a settlement agreement with Labcon North America The S&P/ASX...

On Thursday afternoon the Australian shares were trading lower, in line with Wall Street which closed lower in overnight trade. The market extended losses for the second straight session, led by losses in bank, health care and energy stocks...

The ASX is pulling off a near perfect imitation of a roller coaster, pulling back 0.6% following yesterday’s 1.4% gain and Monday’s 1.8% fall, or an overall drop of 1% for the week. The ASX 200 closed at 7,299 while the ASX Emerging Compani...

The Althea Group Holdings Ltd (ASX: AGH) share price has been a positive performer on Wednesday. In early trade, the cannabis company’s shares are up 4.5% to 33.5 cents. Why is the Althea share price on a high today? Investors have been bu...

Wall Street rebounds as Nasdaq resets record high All three major US benchmarks rose overnight, as investors adjusted to the Fed’s rate outlook. The Dow Jones rose by 0.20%, S&P 500 by 0.51%, and tech heavy Nasdaq by 0.79%. Nasdaq close...

ShareCafeAlthea Group (ASX: AGH) – Hidden Gems Webinar Presenter – Robert Meissner – Chief Financial Officer & Company Secretary – Althea is an Australian licensed producer, supplier and exporter of pharmaceutical-grade medicinal canna...

ShareCafeHidden Gems Webinar Recap – Fresh Leaf Analytics, LGP, CAN, AGH & EMD Catch up on the full webinar with presentations from Fresh Leaf Analytics, Little Green Pharma (ASX: LGP), Cann Group (ASX: CAN) , Althea Group (ASX: AGH),...

Small caps have declined for the fourth time in the past five days — but still finished April with their strongest performance in six months. The Small Ordinaries index gained 4.83 per cent in April despite declining 0.96 per cent this week...

Summary Health House International has signed a non-exclusive distribution agreement with Dragonfly Biosciences. The agreement with Dragonfly would strengthen Health House’s product portfolio within Australia. The distribution agreeme...

Source: photolona, Shutterstock Summary Australian Primary Hemp has signed another retail distribution agreement with Coles Group Limited. Cannabis player Little Green Pharma has entered into a non-exclusive distribution agreement wit...

Source: Yarygin, Shutterstock Summary The Australian cannabis market is flourishing with growing patient numbers and better product selection. Medicinal cannabis player Bod Australia has won a new PO for CBD products for the US cannab...

The S&P/ASX 200 Index (ASX: JXO) is having a pretty decent day today. A the time of writing, the ASX 200 is up a healthy pre-Easter 0.21%. But one group that is doing a quarter-ounce better are ASX cannabis shares. Take Creso Pharma Lt...

Source:ShutterstockProfessional, Shutterstock Summary Althea Group Holdings Limited updated the market with a new and innovative range of its oil-based cannabis products. Cann Group and Emyria have entered in collaboration to accelera...

It wasn’t too long ago that the very idea of ASX cannabis shares was laughable. Aside from a few smoky hash bars in the Netherlands, cannabis use was prosecuted vigorously across most countries. While billions of dollars were earned in glo...

Cannabis companies Cann Group (ASX:CAN) and Emryia (ASX:EMD) are joining forces in a bid to be the first companies to have a low-dose cannabinoid (CBD) product approved for sale in Australian pharmacies without a prescription. They are hopi...

The Althea Group Holdings Ltd (ASX: AGH) share price is pushing high today after announcing a new product launch. At the time of writing, the cannabis company’s shares are up 2% to 53 cents. What did Althea announce? This morning Althea an...

Wall Street record highs, but $35 billion wiped out on Goldman block sale All major indices in the US rose, as an even bigger stimulus package will be announced by the Biden administration this week. The Build Back Better stimulus is a $3 t...

Source: Have a nice day Photo, Shutterstock Summary In the European market, Althea anticipates rapid growth with a £1 billion opportunity in the UK market. Althea has been nominated to supply second-source medicinal cannabis products...

If Mexico moves forward with legalising recreational marijuana use, the ripple effects could boost cannabis shares across the globe. ASX cannabis shares, especially those with international markets in their sites, could enjoy a fresh tailw...

The Althea Group Holdings Ltd (ASX: AGH) share price is pushing higher on Monday morning. At the time of writing, the cannabis company’s shares are up 3% to 53 cents. Why is the Althea share price pushing higher? Investors have been buying...

Source: Olena Yakobchuk ,Shutterstock Summary Althea’s subsidiary, Peak Processing Solutions, obtained a purchase order from Cronos Group’s subsidiary, Peace Naturals, worth ~C$134,000. The agreement allows Peak to extract hydrocarbon...

The Althea Group Holdings Ltd (ASX: AGH) share price is on course to end the week on a positive note. At the time of writing, the cannabis company’s shares are up 2% to 52 cents. Why is the Althea share price pushing higher today? Investor...

The share price of cannabis products producer and distributor Althea Group Holding Ltd [ASX:AGH] has surged as its first-half revenue nearly triples. At time of writing AGH shares are up 5.66% to trade at 56 cent per share... The post Althe...

The Althea Group Holdings Ltd (ASX: AGH) share price is surging higher today following the release of its first-half results. During late morning trade, the cannabis company’s shares are up 8.4% to an intraday high of 57.5 cents. At the ti...

It has been a great start to the week for the Althea Group Holdings Ltd (ASX: AGH) share price. In afternoon trade, the cannabis company’s shares are up almost 8% to 56 cents. This latest gain means the Althea share price is now up over 27...

In what may be a catalyst for ASX cannabis shares, a private company today gained approval to grow medicinal cannabis in Western Australia. As reported by the ABC, the private medicinal cannabis company Elite Cannabinoids has received appr...

The first half of FY21 (1H FY21) saw positive developments for ASX cannabis shares surrounding the regulation of medicinal cannabis products both locally and internationally. International markets were buoyed by the down-scheduling of cann...

Summary The ASX 200 is trading lower on Thursday, down 11.20 points or 0.16 per cent to 6845.70 at 11:33 AM (AEDT), after stock markets worldwide saw choppy trading overnight.  The Australian benchmark equity index has so far seen seve...

Summary ASX cannabis supplier Althea Group completed the export of its first commercial shipment to the UK-based Grow Pharma Group. Althea expanded its agreement with the UK supplier to include two other jurisdictions - the Isle of Man...

The Althea Group Holdings Ltd (ASX: AGH) share price is charging higher on Thursday. In morning trade the cannabis company’s shares are up 7% to 62 cents. Why is the Althea share price charging higher? Investors have been buying Althea sha...

At time of writing, the share price of Althea Group Holdings Ltd [ASX:AGH] is up 10%, trading at 55 cents... The post Althea Share Price Up on First Germany Shipment (ASX:AGH) appeared first on Money Morning Australia.

The Althea Group Holdings Ltd (ASX: AGH) share price is tearing higher today. This comes after the company announced the completion of its first shipment of products to Germany. Shares in the global medicinal cannabis company reached a hig...

Althea Group (ASX:AGH) shares are up this morning after the medical marijuana company announced it had completed its first shipment ... Read More The post Althea Group ships $1m in cannabis oil to German distributor appeared first on Stockh...

Summary The ASX 200 opened higher on Wednesday, gaining 8.90 points or 0.13 per cent to 6,830.10, following a mixed close for Wall Street overnight.  In the opening trade, the top performing stocks on ASX 200 were Graincorp Ltd and Eag...

Summary Althea Group completed its first shipment of medicinal cannabis oil products to Germany. The initial shipment of 2,000 units is valued at around $1 million. Under the agreement, Althea Group would be getting 50 per cent of pro...

Summary Biotechnology company Alterity Therapeutics has obtained funding for its lead candidate, ATH434. The funding will be used for the evaluation of ATH434’s pharmacologic profile in an animal model. The Company will evaluate the o...

Not too many investors are having a good time today. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) is down 2.18% to 6,633points, snapping the healthy momentum that 2021 had brought until now. One ASX sector is fairing a lot...

With Joe Biden due to take office this week, many investors are wondering what this could mean for ASX shares. Ahead of his inauguration Biden has revealed a $1.9 trillion coronavirus relief plan aimed at combating the pandemic and the eco...

There is a sector in Australia that’s about to grow its revenue by 478% in the current financial year, according to one analyst. Consumer research firm IBISWorld revealed Tuesday that the medical cannabis manufacturing industry is currentl...

Summary Althea achieved record sales of A$1.19 million in December 2020, an increase of 40% compared to the previous month. The Company witnessed a month-on-month increase of 22% in sales across the Australian market. The medicinal ca...

The Althea Group Holdings Ltd (ASX: AGH) share price is tearing higher this morning after the company posted a record monthly sales result. At the time of writing, Althea shares are swapping hands for 46 cents per share, giving the company...

If 2020 taught us anything, it was the importance of quality healthcare. The COVID-19 pandemic put unprecedented demand on global health services, with many providers rising to the challenge. Healthcare has long been seen as a defensive in...